Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
<p>Abstract</p> <p>Perivascular epithelioid cell tumor (PEComa) is an extremely rare neoplasm that appears to arise most commonly at visceral (especially gastrointestinal and uterine), retroperitoneal, and abdominopelvic sites. Malignant PEComas exist but are very rare. These tumor...
Main Authors: | Gennatas Constantine, Michalaki Vasiliki, Vasilatou Kairi Paraskevi, Kondi-Paphiti Agathi, Voros Dionysios |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://www.wjso.com/content/10/1/181 |
Similar Items
-
Perivascular Epithelioid Cell Tumors (PEComas) Refractory to mTOR Inhibitors
by: San-Chi Chen, et al.
Published: (2014-09-01) -
Perivascular epithelioid cell tumor of the gastrointestinal tract
by: Tsung-Hao Liu, et al.
Published: (2016-03-01) -
Malignant Subcutaneous Perivascular Epithelioid Cell Tumor of Anterior Abdominal Wall
by: David Eng Yeow Gan, et al.
Published: (2021-03-01) -
Radiological findings of two neoplasms with perivascular epithelioid cell differentiation
by: Timothy Diestelkamp, BS, et al.
Published: (2017-12-01) -
VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature
by: Aikaterini Liapi, et al.
Published: (2021-03-01)